Exagen Inc.
XGN
$4.60
-$0.29-5.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.24% | 10.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.24% | 10.99% | |||
| Cost of Revenue | 5.32% | 6.78% | |||
| Gross Profit | -3.08% | 13.94% | |||
| SG&A Expenses | -0.84% | 3.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.58% | 5.14% | |||
| Operating Income | -17.87% | 21.84% | |||
| Income Before Tax | -60.97% | -17.32% | |||
| Income Tax Expenses | -97.30% | -- | |||
| Earnings from Continuing Operations | -59.65% | -18.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -59.65% | -18.31% | |||
| EBIT | -17.87% | 21.84% | |||
| EBITDA | -14.97% | 26.02% | |||
| EPS Basic | -46.75% | -4.10% | |||
| Normalized Basic EPS | -10.57% | 13.92% | |||
| EPS Diluted | -46.75% | -4.10% | |||
| Normalized Diluted EPS | -10.57% | 13.92% | |||
| Average Basic Shares Outstanding | 8.80% | 13.62% | |||
| Average Diluted Shares Outstanding | 8.80% | 13.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||